Management of Coronavirus Infection during Pregnancy and Puerperium

International Journal of Caring Sciences, cilt.14, sa.2, ss.1514-1526, 2021 (Hakemli Dergi)

Abstract

Coronavirus infection (COVID-19) has spread rapidly all over the world and turned into a pandemic. Rapid

spreading, human-to-human transmission, lack of any definitive treatment, and fatality associated with this

disease have a significant impact on public health, making it difficult to control. No increased sensitivity to

COVID-19 has been reported in pregnant women compared to the general population. However, pregnant

women are more susceptible to diseases than those who are not pregnant, and morbidity and mortality rates are

higher. Pregnancy and postpartum management of suspicious or infected pregnancies should be performed by a

competent team in this regard due to the high mortality rates associated with similar viruses, SARS-CoV and

MERS-CoV infections, in pregnant women. The mortality rate due to SARS-CoV infection is about 25%. There

is limited information about COVID-19 infection in pregnant women, and for the time being, treatment

management is similar to that in non-pregnant women. Some pregnant patients have fetal distress and preterm

labor. There is no evidence that coronavirus can spread from mother to baby. Nevertheless, on February 6, 2020,

the SARS-CoV 2 test was found to be positive 36 hours after delivery in the newborn of a woman who was

COVID-19 positive. In line with all this information, necessary measures should be taken to prevent

contamination in pregnant and puerperal women, and appropriate treatment method should be applied.

Keywords: Pregnancy; Birth; Covid-19; Puerperıum ; Medicament